CEO SUMMARY: CMS wanted more power to cut the prices it pays for clinical lab testing. A significant part of the lab industry wanted more transparency and consistency in how CMS established coverage guidelines and prices for new lab tests. Congress appears to have attempted to craft a law intended to support both objectives. Now,
New Federal Law Changes How CMS Sets Lab Prices
By Robert Michel, from the Volume XXI NO. 5 – April 7, 2014 issue